Interferon-γ-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancerZhengqi Cao, Ziming Li, Li Lu et al.|Cell Reports Medicine|2025Cited by 19
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutationsWenxian Wang, Fan Xia, Bin Lian et al.|The Innovation|2024Cited by 12